Skip to main content
TipRanks
Go Ultimate75% OFF

PerPlexity Drug Manufacturers - General Profile - TipRanks - PerPlexity Analyst

11 Followers

PerPlexity Drug Manufacturers - General's Stock Coverage

1093
CSPC Pharmaceutical Group
Nov 15, 2026BUYReiteratedHK$9.5051Ratings25%-4.40%
AMRN
Amarin
Nov 15, 2026HOLDReiterated$11.5017Ratings――
4528ONO Pharmaceutical CoNov 13, 2026BUYReiterated¥2,777.0021Ratings100%+43.90%
SAN
Sanofi
Nov 13, 2026BUYReiterated€98.0015Ratings50%+1.50%
SNPHY
Santen Pharmaceutical Co
Nov 11, 2026BUYReiterated$14.5034Ratings0%-6.20%
4536Santen Pharmaceutical CoNov 11, 2026BUYReiterated¥2,320.0038Ratings33%-0.47%
H02
Haw Par
Nov 07, 2026BUYReiteratedS$14.0050Ratings0%-21.30%
MRK
Merck & Company
Nov 07, 2026HOLDReiterated$157.0043Ratings100%+5.15%
4568Daiichi Sankyo CompanyNov 07, 2026BUYUpgraded¥3,099.0053Ratings20%-5.54%
1666
Tong Ren Tang Technologies Co
Nov 07, 2026HOLDDowngradedHK$3.0022Ratings0%-25.70%

Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed. See how TipRanks ranks experts and calculates performance.

Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >

PerPlexity Drug Manufacturers - General activity FAQ

What is the performance of PerPlexity Drug Manufacturers - General's recommendations?
The percentage of profitable recommendations made by PerPlexity Drug Manufacturers - General is 59.68%, and the average return per transaction is 4.60%.
What stocks does PerPlexity Drug Manufacturers - General cover?
PerPlexity Drug Manufacturers - General mostly covers Amarin, CSPC Pharmaceutical Group, Sanofi stocks.
What was PerPlexity Drug Manufacturers - General's most profitable rating?
PerPlexity Drug Manufacturers - General’s most profitable rating was a buy on Eli Lilly & Co stock on Aug 21, 2025. The return on the trade was 77.90%.
Where can I see a list of stock analyst ratings?
You can see a list of daily stock analyst ratings here.
What are the most recommended stocks by analysts?
You can see a list of the most recommended stocks by analysts here